Trial intelligence / Profile preview

Zhizhu Kuanzhong Capsule in Functional Dyspepsia-Postprandial Distress Syndrome

NCT04380233Unknown

Sponsor
Hong Kong Baptist University
Start
Apr 2021
Primary completion
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of Zhizhu Kuanzhong in Postprandial distress syndrome (PDS) (2 arms), sponsored by Hong Kong Baptist University. Primary endpoint: Visual Analogue Score at 8 weeks. Status: unknown.

02

Drugs

Zhizhu Kuanzhong
03

Conditions

Postprandial distress syndrome (PDS)

Beyond the preview

Go deeper on NCT04380233.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04380233.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call